Full-Time

Business Intelligence

BI, Manager

Updated on 8/26/2026

Integer Holdings Corporation

Integer Holdings Corporation

1,001-5,000 employees

Medical device CDMO for cardiac devices

No salary listed

Remote in USA + 1 more

More locations: Plano, TX, USA

Hybrid

Periodic travel is required.

Bachelor's

Category
Data & Analytics (1)
Required Skills
Power BI
ERP
Data Visualization
ETL
SAP Products
Data Engineering
Data Modeling
Data Governance
Oracle
Data Analysis
Snowflake

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Requirements
  • A bachelor’s degree in computer science, information systems, business administration, or a related field.
  • At least 5 years of hands-on experience in business intelligence, data analytics, or related roles, including team leadership.
  • Proven experience designing, developing, and administering business intelligence solutions using Microsoft Power BI.
  • Experience with cloud data warehousing, ETL/ELT tools, and ERP systems.
  • Ability to work effectively with business stakeholders to understand priorities and deliver impactful business intelligence solutions.
  • A deep understanding of business intelligence concepts, data visualization, and analytics methodologies.
  • Strong data modeling, requirements analysis, and solution architecture skills.
  • Ability to translate complex data and analytics concepts into clear, actionable business insights.
  • Change management skills and the ability to operate effectively in a fast-paced environment.
  • Familiarity with software development life cycle and project management methodologies.
  • Ability to lead change and motivate cross-functional teams to achieve tactical and strategic goals.
  • Ability to deliver consistently under deadlines and execute with minimal direction.
  • Excellent conceptual, organizational, analytical, and problem-solving skills.
  • Ability to attract, retain, and develop high-caliber talent.
  • Periodic travel is required.
Responsibilities
  • Lead, mentor, and develop a team of business intelligence analysts and developers.
  • Engage with business stakeholders to understand, analyze, and document business requirements, processes, and reporting needs.
  • Oversee the design, development, and maintenance of enterprise business intelligence dashboards, key performance indicators, and reports using Microsoft Power BI and other business intelligence platforms.
  • Ensure business intelligence solutions adhere to best practices for performance, usability, data governance, and security.
  • Manage and prioritize business intelligence project requests, ensuring alignment with business objectives and timely delivery.
  • Facilitate meetings, document action items, and drive resolution of issues related to business intelligence initiatives.
  • Communicate project status, issue escalations, and resolutions to all levels of the organization.
  • Develop and maintain documentation for business intelligence solutions, including data sources, transformations, and report specifications.
  • Support system maintenance by reviewing application patches, documenting test plans, and executing test scripts.
  • Define and implement business intelligence strategy, standards, and processes to ensure consistent and reliable reporting across the organization.
  • Collaborate with data and analytics architecture and engineering teams to integrate business intelligence solutions with cloud data warehouse platforms and data pipelines.
  • Partner with business units to identify opportunities to leverage business intelligence and analytics to drive business outcomes.
  • Oversee data quality management and ensure the accuracy, completeness, and timeliness of business intelligence data.
  • Support data governance initiatives, including master data management and metadata management for business intelligence assets.
  • Foster a data-driven culture and promote data literacy across the enterprise through training and communication.
  • Stay current with emerging business intelligence technologies and trends, advising on best practices and potential innovations.
  • Participate in steering committees and governance councils to review and prioritize business intelligence and analytics projects.
  • Support efforts to move the on-premises Oracle enterprise resource planning system to a cloud-based enterprise resource planning system.
Desired Qualifications
  • Experience designing, developing, and administering business intelligence solutions using business intelligence platforms other than Microsoft Power BI.
  • Experience with Snowflake cloud data warehousing.
  • Experience with Azure Data Factory ETL/ELT tools.
  • Experience with Oracle and SAP enterprise resource planning systems.
  • Experience in a manufacturing or operational setting.
Integer Holdings Corporation

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 3, 2026 KKR deal prices Integer at $127, a 51.8% premium.
  • Second-quarter 2026 revenue hit $464.1 million and adjusted EPS reached $1.60.
  • KKR promised capacity, technology, and talent investment, plus employee ownership after closing.

What critics are saying

  • KKR closing slips past year-end 2026 if antitrust or stockholder votes fail.
  • Halper Sadeh's August 2026 investigation fuels litigation over fairness and disclosure.
  • New Ross shutdown exposed demand volatility and labor pain; repeat interruptions threaten margins and credibility.

What makes Integer Holdings Corporation unique

  • Integer's 2026 KKR sale confirms sticky device-manufacturing scale and regulatory know-how.
  • Its CDMO footprint serves interventional cardiology, neuromodulation, and orthopedics across global customers.
  • New Ross and other plants give Integer specialized capacity competitors cannot quickly replicate.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Adoption Assistance

Parental Leave

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 16th, 2026
Healthcare stocks outpace S&P 500 by 13 percentage points over six months

Healthcare stocks have returned 26.1% over the past six months, outperforming the S&P 500 by 13.1 percentage points. However, investors must remain cautious due to heavy regulation affecting earnings potential. Integer Holdings faces concerns with 6.1% annual revenue growth over two years, lagging healthcare peers. Its modest revenue base of $1.84 billion provides less fixed cost leverage than larger competitors. The company trades at $125.07 per share, or 18.6 times forward price-to-earnings. Evolent Health shows weak platform performance and declining returns on capital. Its high net-debt-to-EBITDA ratio of 7 times could force unfavourable capital raises if market conditions worsen. Shares trade at $4.15, representing 12.4 times forward price-to-earnings. Tenet Healthcare, operating hospitals and surgical centres across nine US states, emerges as the recommended healthcare investment.

Yahoo Finance
Aug 4th, 2026
Integer Holdings acquired by KKR for $5.7B in all-cash deal at $127 per share

Integer Holdings agreed to be acquired by private equity firm KKR in an all-cash deal valued at approximately $5.7 billion. The transaction values the medical technology company at $127 per share. Shares jumped 2.7% in afternoon trading, continuing a rally from the previous session when the stock surged over 20% following the announcement. The acquisition news overshadowed strong second-quarter results, where Integer posted an adjusted profit of $1.60 per share on $464.1 million in revenue, surpassing analyst estimates. Following the buyout announcement, Integer withdrew its previously issued financial guidance and cancelled its upcoming earnings conference call. Shares traded at $124.50, marking a new 52-week high.

BizWire Express
Aug 3rd, 2026
KKR to acquire Integer for $5.7B in all-cash deal at $127 per share

KKR has agreed to acquire Integer Holdings Corporation, a medical device contract development and manufacturing organisation, in an all-cash transaction valued at approximately $5.7 billion. Integer stockholders will receive $127 per share, representing a 51.8% premium to the company's closing share price on 29 April 2026. The acquisition follows a comprehensive strategic review announced by Integer in April 2026. The Integer Board unanimously approved the agreement and recommends stockholder approval. KKR plans to invest in Integer's capacity, technology, innovation, and talent. The firm also intends to establish a broad-based employee ownership programme following the transaction's close, consistent with its approach across portfolio companies. The transaction is expected to close by year-end, subject to stockholder approval and regulatory clearances. Upon completion, Integer will become privately held and delist from the New York Stock Exchange.

Yahoo Finance
Aug 3rd, 2026
Integer Holdings beats Q2 expectations with $464M revenue and $1.60 earnings per share

Integer Holdings Corp. reported second-quarter net income of $23.6 million, or 69 cents per share. Adjusted earnings came to $1.60 per share, exceeding Wall Street expectations of $1.38 per share. The Plano, Texas-based medical device outsource manufacturer posted revenue of $464.1 million for the period, also beating analyst forecasts of $452.5 million. The results surpassed predictions from five analysts surveyed by Zacks Investment Research on both earnings and revenue metrics.

Financial Modeling Prep
Aug 3rd, 2026
KKR & Co Inc (NYSE: KKR) Acquires Integer Holdings Corporation (NYSE: ITGR): key insights into the medical device acquisition.

KKR & Co Inc (NYSE: KKR) Acquires Integer Holdings Corporation (NYSE: ITGR): key insights into the medical device acquisition. Aug 03, 2026 Market News FMPKKR & Co Inc (NYSE: KKR) Acquires Integer Holdings Corporation (NYSE: ITGR):... * Integer Holdings Corporation (NYSE: ITGR) is being acquired by KKR (NYSE: KKR) for approximately $5.70 billion at $127.00 per share. * The acquisition price represents a 51.80% premium over Integer's closing price on April 29, 2026. * An investor rights law firm, Halper Sadeh LLC, is investigating the acquisition to ensure a fair price for shareholders and compliance with federal securities laws. Integer Holdings Corporation is a leading medical-device outsourcing company. It helps other companies develop and manufacture medical devices. On August 3, 2026, global investment firm KKR announced it will acquire Integer in a deal valued at an enterprise value of approximately $5.70 billion. An analyst at Truist Financial (NYSE: TFC) set a new price target for Integer at $127.00. This price target directly matches the $127.00 per share all-cash offer made by KKR for the acquisition. The acquisition follows a strategic review process conducted by Integer's board of directors. The analyst also downgraded the stock to a "Hold" rating. A "Hold" rating suggests that the stock's price is not expected to move much. This is common after an acquisition announcement, as the stock price tends to stay close to the agreed-upon purchase price until the deal is finalized. The $127.00 per share offer is a 51.80% premium over Integer's closing price on April 29, 2026. It is also a 28.80% premium to the 30-day volume-weighted average price (VWAP) as of July 31, 2026. VWAP is the average price a stock has traded at over a period, adjusted for trading volume. Despite the premium, an investor rights law firm, Halper Sadeh LLC, is investigating the sale. As highlighted by Business Wire, the firm is looking into whether Integer's board secured a fair price for its shareholders and followed federal securities laws during the process. Market news and analyst rating coverage Rayan Ahmad covers market news, analyst rating changes, and company developments for the FMP blog. His work focuses on summarizing price-target updates, earnings results, and broker actions into accessible, data-backed market updates. Financial data for every need. Real-time quotes and 30+ years of historical data, including prices, fundamentals, and insider transactions - all accessible via API. Stock Screener 2017-2026 (C) FMP